All News #Library
Biotech
Arbutus Gets FDA Fast Track For Imdusiran In Chronic Hepatitis B
15 Apr 2026 //
GLOBENEWSWIRE
Arbutus Reports 2025 Financial Results And Corporate Update
23 Mar 2026 //
GLOBENEWSWIRE
Arbutus Reports Q2 2025 Financials, Updates on Corporate Progress
06 Aug 2025 //
GLOBENEWSWIRE
Arbutus Regains China Rights to Potential Hep B Cure from Qilu
25 Jun 2025 //
FIERCE BIOTECH
Arbutus Reacquires Greater China Rights to Imdusiran
25 Jun 2025 //
GLOBENEWSWIRE
Arbutus Presents HBV Assets Data at EASL Congress 2025
07 May 2025 //
GLOBENEWSWIRE
Arbutus to Present Imdusiran, AB-101 Data at EASL Congress 2025
23 Apr 2025 //
GLOBENEWSWIRE
Arbutus & Barinthus Report Nivolumab raise HBsAg Loss in Hepatitis B
15 Nov 2024 //
GLOBENEWSWIRE
Judge Rules Against Moderna in COVID-19 Patent Fight with Roivant Subsidiary
04 Apr 2024 //
BIOSPACE
Arbutus Biopharma and Barinthus Bio Present Preliminary Data from VTP-300
09 Nov 2023 //
GLOBENEWSWIRE
Arbutus ends COVID, RNA destabilizer plans over preclinical data
12 Sep 2023 //
FIERCE BIOTECH
Arbutus Announces Dosing of First Subject in the Phase 1a/1b Trial with AB-101
11 Sep 2023 //
GLOBENEWSWIRE
Arbutus Presents Preliminary AB-729 & Pegylated Interferon Alfa-2a Combination
21 Jun 2023 //
GLOBENEWSWIRE
Arbutus to Present AB-729 and AB-836 Data at EASL Congress 2023
07 Jun 2023 //
GLOBENEWSWIRE
Arbutus Provides AB-729 Clinical Data and AB-161 Preclinical Data
27 Apr 2023 //
GLOBENEWSWIRE
Arbutus Announces FDA Clinical Hold on IND Application for AB-101
25 Apr 2023 //
GLOBENEWSWIRE
Arbutus to Present AB-729 and AB-161 Data at the Global Hepatitis Summit 2023
18 Apr 2023 //
GLOBENEWSWIRE
Court upholds prior strike of Arbutus patent in Moderna case
12 Apr 2023 //
FIERCE PHARMA
Moderna notches a win in long-running Arbutus patent fight
12 Apr 2023 //
ENDPTS
Arbutus files patent lawsuit against Pfizer/BioNTech over COVID vaccines
05 Apr 2023 //
REUTERS
Moderna loses bid to shift liability in COVID-19 vaccine patent case
11 Mar 2023 //
REUTERS
U.S. backs Moderna, says government should face COVID-19 vaccine lawsuit
15 Feb 2023 //
REUTERS

Market Place
Sourcing Support